GlassScriptPhysician profile
Christy Tran Kleinke
NPI 1205017720
$9,469.92
in general payments reported to CMS, 2019-2025
55 companies · $1,653 in 2025
The $1,653 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $409 · 2021: $890 · 2022: $1,980 · 2023: $2,019 · 2024: $2,324 · 2025: $1,653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,923 · Education: $50.00 · Consulting Fee: $23.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,923.25 |
| Education | $50.00 |
| Consulting Fee | $23.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,698.50 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,597.65 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $781.33 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Pfizer INC. | $574.21 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $490.67 | 2021-2025 | |
| Amgen INC. | $362.60 | 2019-2025 | Evenity, Repatha, Otezla |
| Vanda Pharmaceuticals INC. | $355.55 | 2020-2023 | Hetlioz, Fanapt |
| Abbott Laboratories | $259.01 | 2021-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Novo Nordisk INC | $252.42 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $217.78 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $203.88 | 2019-2025 | Jardiance |
| Allergan, INC. | $153.88 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $153.61 | 2019-2024 | Spravato |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $149.02 | 2021-2025 | Xifaxan, Trulance |
| Biohaven Pharmaceutical Holding Company LTD. | $141.10 | 2022 |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $140.88 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $139.28 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $138.91 | 2023-2025 | Gemtesa |
| Astellas Pharma US INC | $134.09 | 2021-2025 | Veozah |
| Merck Sharp & Dohme LLC | $114.99 | 2019-2025 | Vaxneuvance, Gardasil 9, Capvaxive |
| Exact Sciences Corporation | $111.94 | 2023-2024 | Cologuard Collection Kit |
| Nestle Healthcare Nutrition INC. | $104.24 | 2021-2022 | |
| Grifols USA, LLC | $87.14 | 2019-2022 | |
| Medtronic, INC. | $83.06 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $80.55 | 2022-2023 | Austedo, Austedo Xr |
| Sanofi Pasteur INC. | $70.66 | 2022-2023 | |
| Daiichi Sankyo INC. | $66.65 | 2020-2022 | |
| Dexcom, INC. | $61.37 | 2023-2025 | Dexcom G6 Transmitter |
| Biohaven Pharmaceuticals, INC. | $60.80 | 2021 | |
| Currax Pharmaceuticals LLC | $50.00 | 2023 | Nexletol |
| Amarin Pharma, INC. | $48.64 | 2020-2022 | |
| Hologic Sales and Service, LLC | $46.16 | 2024 | Aptima, Thinprep 2000 Processor |
| Corium, LLC | $44.06 | 2023-2024 | Azstarys |
| Intuitive Surgical, INC. | $40.05 | 2025 | |
| Ibsa Pharma INC. | $32.96 | 2024-2025 | Licart, Tirosint, Flector |
| Aimmune Therapeutics, INC. | $30.59 | 2024-2025 | Zenpep |
| Edwards Lifesciences Corporation | $29.72 | 2025 | Sapien 3 Ultra Resilia |
| Otsuka America Pharmaceutical, INC. | $29.53 | 2024-2025 | Rexulti |
| Insightec,INC | $28.35 | 2023 | Exablate |
| Abiomed | $27.73 | 2024 | Impella |
| Cranial Technologies, INC | $27.44 | 2020-2021 | |
| Baxter Healthcare | $27.08 | 2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $24.94 | 2025 | |
| Echosens North America, INC. | $23.00 | 2023 | Fibroscan |
| Esperion Therapeutics, INC. | $22.36 | 2021 | |
| Vbi Vaccine (Delaware) INC. | $22.07 | 2022 | |
| Inspire Medical Systems, INC. | $21.59 | 2023 | Inspire |
| Alfasigma USA, INC. | $16.22 | 2021 | |
| Philips North America LLC | $15.48 | 2024 | (Ck7) Extended Holter |
| Takeda Pharmaceuticals U.S.A., INC. | $14.71 | 2023 | Vpriv |
| Regeneron Healthcare Solutions, INC. | $14.40 | 2023 | Dupixent |
| Lundbeck LLC | $13.48 | 2022 | |
| Lucid Diagnostics INC. | $12.28 | 2022 | |
| Seqirus USA INC | $11.89 | 2022 | |
| Ossur Americas, INC. | $9.42 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christy Kleinke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.